These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28740338)

  • 1. Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract.
    Ferrigno A; Berardo C; Di Pasqua LG; Siciliano V; Richelmi P; Vairetti M
    World J Gastroenterol; 2017 Jul; 23(25):4500-4507. PubMed ID: 28740338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of metabotropic glutamate receptor 5 in learning and memory processes.
    Simonyi A; Schachtman TR; Christoffersen GR
    Drug News Perspect; 2005; 18(6):353-61. PubMed ID: 16247513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators.
    Bennett KA; Christopher JA; Tehan BG
    Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral versus central modulation of gastric vagal pathways by metabotropic glutamate receptor 5.
    Young RL; Page AJ; O'Donnell TA; Cooper NJ; Blackshaw LA
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G501-11. PubMed ID: 17053158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of metabotropic glutamate 5 receptor in visceral pain.
    Lindström E; Brusberg M; Hughes PA; Martin CM; Brierley SM; Phillis BD; Martinsson R; Abrahamsson C; Larsson H; Martinez V; Blackshaw AL
    Pain; 2008 Jul; 137(2):295-305. PubMed ID: 17937975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Blockade of the Metabotropic Glutamate Receptor mGluR5 Protects Mouse Livers in In Vitro and Ex Vivo Models of Ischemia Reperfusion Injury.
    Ferrigno A; Berardo C; Di Pasqua LG; Siciliano V; Richelmi P; Nicoletti F; Vairetti M
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
    Hughes ZA; Neal SJ; Smith DL; Sukoff Rizzo SJ; Pulicicchio CM; Lotarski S; Lu S; Dwyer JM; Brennan J; Olsen M; Bender CN; Kouranova E; Andree TH; Harrison JE; Whiteside GT; Springer D; O'Neil SV; Leonard SK; Schechter LE; Dunlop J; Rosenzweig-Lipson S; Ring RH
    Neuropharmacology; 2013 Mar; 66():202-14. PubMed ID: 22551786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.
    Harvey BD; Siok CJ; Kiss T; Volfson D; Grimwood S; Shaffer CL; Hajós M
    Neuropharmacology; 2013 Dec; 75():19-30. PubMed ID: 23831682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article.
    Kuhn R; Pagano A; Stoehr N; Vranesic I; Flor PJ; Lingenhöhl K; Spooren W; Gentsch C; Vassout A; Pilc A; Gasparini F
    Amino Acids; 2002; 23(1-3):207-11. PubMed ID: 12373539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic glutamate receptor 5 as a potential target for smoking cessation.
    Chiamulera C; Marzo CM; Balfour DJK
    Psychopharmacology (Berl); 2017 May; 234(9-10):1357-1370. PubMed ID: 27847973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthosteric and allosteric drug binding sites in the Caenorhabditis elegans mgl-2 metabotropic glutamate receptor.
    Tharmalingam S; Burns AR; Roy PJ; Hampson DR
    Neuropharmacology; 2012 Sep; 63(4):667-74. PubMed ID: 22652059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells.
    Neugebauer V; Chen PS; Willis WD
    J Neurophysiol; 1999 Jul; 82(1):272-82. PubMed ID: 10400956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mGluR5: exploration of orthosteric and allosteric ligand binding pockets and their applications to drug discovery.
    Mølck C; Harpsøe K; Gloriam DE; Mathiesen JM; Nielsen SM; Bräuner-Osborne H
    Neurochem Res; 2014 Oct; 39(10):1862-75. PubMed ID: 24493625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
    Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
    Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of lateral hypothalamic mGlu1 and mGlu5 receptors elicits feeding in rats.
    Charles JR; Duva MA; Ramirez GJ; Lara RL; Yang CR; Stanley BG
    Neuropharmacology; 2014 Apr; 79():59-65. PubMed ID: 24219858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro binding of a radio-labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5.
    Zysk JR; Spear N; Fieles W; Stein MM; Sygowski LS; King MM; Hoesch V; Hastings R; Brockel B; Do M; Ström P; Gadient R; Chhajlani V; Elmore CS; Maier DL
    Synapse; 2013 Mar; 67(3):135-44. PubMed ID: 23150216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders.
    Spooren WP; Gasparini F; Salt TE; Kuhn R
    Trends Pharmacol Sci; 2001 Jul; 22(7):331-7. PubMed ID: 11431019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational analysis of negative and positive allosteric modulator binding and function in metabotropic glutamate receptor 5 (in)activation.
    Dalton JA; Gómez-Santacana X; Llebaria A; Giraldo J
    J Chem Inf Model; 2014 May; 54(5):1476-87. PubMed ID: 24793143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homer1/mGluR5 activity moderates vulnerability to chronic social stress.
    Wagner KV; Hartmann J; Labermaier C; Häusl AS; Zhao G; Harbich D; Schmid B; Wang XD; Santarelli S; Kohl C; Gassen NC; Matosin N; Schieven M; Webhofer C; Turck CW; Lindemann L; Jaschke G; Wettstein JG; Rein T; Müller MB; Schmidt MV
    Neuropsychopharmacology; 2015 Mar; 40(5):1222-33. PubMed ID: 25409593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
    Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
    Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.